On July 1, 2026, two insiders at Oscar Health, Inc. (OSCR) executed significant stock sales, divesting shares valued at approximately $30.07 million.
Chief Executive Officer Mark T. Bertolini was involved in these transactions, selling a total of 1,044,480 shares across two separate sales. The first sale consisted of 555,826 shares at an average price of $29.17 per share, totaling $16.21 million. This was followed by a sale of 488,654 shares at an average price of $28.35 per share, amounting to $13.85 million.
While insider selling can stem from various personal financial decisions such as diversification or tax planning, the aggregate value and involvement of multiple transactions by a key executive may draw investor attention.